Tristel’s Disinfectant Boosts Urology Practice Efficiency
Company Announcements

Tristel’s Disinfectant Boosts Urology Practice Efficiency

Tristel plc (GB:TSTL) has released an update.

Tristel plc has been spotlighted at the American Urological Association 2024 conference for its Tristel™ ULT product, a novel high-level disinfectant praised for streamlining urological procedures. The white paper presented emphasizes Tristel™ ULT’s effectiveness against pathogens and its ability to significantly reduce reprocessing time for medical devices, thereby increasing the efficiency of urology practices. Following FDA approval, Tristel has seen growing brand recognition in the US market, with expectations for further progress bolstered by the recent case study.

For further insights into GB:TSTL stock, check out TipRanks’ Stock Analysis page.

Related Articles
Austin AngeloTristel (TSTL) Announces Q4 Dividend: Read On for Important Dates
TipRanks UK Auto-Generated NewsdeskTristel PLC Achieves Record Growth in 2024
TipRanks UK Auto-Generated NewsdeskTristel PLC Announces Upcoming Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App